Allergic rhinitis and quality of life: Where are we?

Clinical and Experimental Allergy Reviews

Volumn 3, Issue 3, 2003, Pages 90-94

  Majani, G ^a   Baiardini, I ^a,b   Giardini, A ^a   Pasquali, M ^b   Tosca, M A ^b   Canonica, G W ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Adherence; Allergic rhinitis; Caregiver; Generic and specific instruments; Quality of Life

Indexed keywords

ALLERGIC RHINITIS; CAREGIVER; CONFERENCE PAPER; HUMAN; PATIENT SATISFACTION; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; TREATMENT OUTCOME;

EID: 0346846718     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2003.00019.x     Document Type: Conference Paper

References (43)

1. Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users' guides to the medical literature. XII - How to use articles about health-related quality of life. JAMA 1997; 277:1232-7.
2. Majani G. L'osservatorio sulla Qualità della Vita. Giornale Italiano Cardiologia 1996; 26:689-97.
3. Smith KW, Avis NA, Assmann SF. Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Quality Life Res 1999; 8:447-59.
4. Majani G, Pierobon A, Giardini A, Callegari S, Opasich C, Cobelli F, Tavazzi L. Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity. Eur Heart J 1999; 20:1579-86.
5. Zeidner M, Endler NS, eds. Handbook of Coping. Theory, Research and Applications. New York: John Wiley and Sons, 1996.
6. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ 1986; 134:889-95.
7. Blaiss MS. Outcome analysis in asthma. JAMA 1997; 278:1874-80.
8. Guyatt G, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurments properties? J Clin Epidemiol 1992; 45:1341-5.
9. Bergner M, Bobbit RA, Carter WB, Gilson BS. The sickness impact profile; development and final, version of a health status measure. Med Care 1981; 19:787-805.
10. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J Epidem Community Health 1980; 34:281-6.
11. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, 1993.
12. Majani G, Pierobon A, Giardini A, Callegari S. Satisfaction Profile (SAT-P) in 732 patients. Focus on subjectivity in HRQoL assessment. Psychol Health 2000; 15:1-14.
13. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83.
14. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000; 30:132-40.
15. Wasserfallen JB, Gold K, Schulman KA, Baraniuk JN. Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. J Allergy Clin Immunol 1997; 100:16-22.
16. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94:182-8.
17. De Graaf-in't Veld T, Koenders S, Garrelds IM, van Wijk RG. The relationship between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1996; 98:508-13.
18. Juniper EF, Guyatt GH, Archer B, Ferrie PJ. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: Further exploration of 'as needed' use. J Allergy Clin Immunol 1993; 92:66-72.
19. Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolzed budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 1993; 70:225-30.
20. Bousquet J, Duchateau J, Pignat JC, Fayol C, Marquis P, Mariz S, Ware JE, Valentin B, Burtin B. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 Questionnaire. J Allergy Clin Immunol 1996; 98:309-16.
21. Harvey RP, Comer C, Sanders B, Westley R, Marsh W, Shapiro H, Wiener M. Model for outcomes assessments of antihistamine use for seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:1233-41.
22. Bagenstose SE, Bernstein JA. Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes. Ann Allergy Asthma Immunol 1999; 83:524-8.
23. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCI improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1999; 83:311-7.
24. Condemi J, Schulz R, Lim J. Triamcicolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy on quality of life. Ann Allergy Asthma Immunol 2000; 84:533-8.
25. Burtin B, Duchateau J, Pignat JC, Donnelly F, Bousquet J. Further improvement of quality of life by cetirizine in perennial allergic rhinitis as a function of treatment duration. J Invest Allergol Clin Immunol 2000; 10:66-70.
26. Juniper EF. Rhinitis management: the patient's perspective. Clin Exp Allergy 1998; 28:34-8.
27. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis 1985; 38:27-36.
28. Editorial. Quality of life and clinical trials. Lancet 1995; 346:1-2.
29. Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997; 278:47-50.
30. Heymann J. Building partnerships with patients. Ann Allergy Asthma Immunol 1997; 78:1-4.
31. Majani G, Baiardini I, Giardini A, Senna GE, Minale P, D'Ulisse S, Ciprandi G, Canonica GW. Health related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001; 56:313-7.
32. Casale T, Lazarus SC. Immunology of asthma and rhinitis: pathogenic factors and therapeutic options. Am J Resp Crit Care Med 1999; 160:1778-87.
33. Leynaert BJ, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in non atopic subjects: Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104:301-4.
34. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study on young adults. Am J Respir Crit Care Med 2000; 162:1391-6.
35. Simons FER. Allergic Rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 1994; 104:534-40.
36. Passalacqua G, Ciprandi G, Canonica GW. United airway diseases: therapeutic implications. Thorax 2000; 55:s26-s27.
37. Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: the United airway diseases. Curr Opinion Allergy Clin Immunol 2001; 1:7-13.
38. Majani G, Baiardini I, Pasquali M, Venturi S, Passalacqua G, Canonica GW. Development of a new questionnaire to assess the impact of rhinoconjunctivitis and/or asthma on patients' life. Eur Resp J 2000; 16:351s.
39. Majani G, Baiardini I, Pasquali M, Venturi S, Passalacqua G, Canonica GW. Unpublished data.
40. Majani G, Baiardini I, Giardini A, Ciprandi G, Tosca MA, Pasquali M, Canonica GW. The impact of children's asthma and rhinitis on caregiver. J Allergy Clin Immunol 2000; 105:S317.
41. Myers LB, Midence K. Concepts and issues in adherence. In: Myers LB, Midence K, eds. Adherence to Treatment in Medical Conditions. Amsterdam: Overseas Publishers Association, 1998: 1-24.
42. Meichenbaum D, Turk DC. Facilitating Treatment Adherence. A Practitioner's Guidebook. New York: Plenum Press, 1987.
43. Blumenthal D. Quality of health care. Part 4: the origins of the quality-of-care debate. N Engl J Med 1996; 10:1146-8.